MATWIN is an accelerator program aiming at challenging and maximizing innovation transfer potential exclusively on oncology. Through a support course 6 months, candidates will have access to support through expertise, coaching/mentoring and a qualified network of partners likely to help them accelerate the development of their project.
When applying to the MATWIN accelerating program, you will:
- Assess and increase the potential of your project in the discovery / preclinical development phase from MATWIN coaching process
- Obtain validation guidelines for your development plan (clinical strategy, indications, milestones, regulatory guidance etc.) from MATWIN International Board),experts in the field and KOLs
- Get ready for the investment phase thanks to numerous individual high added-value MATWIN coaching / mentoring sessions
- Optimize your partnership opportunities with biotechs / pharmas / investors
The program is open to European candidates (academic team or start-up) developing an innovative R&D product or solution in oncology, such as therapeutics, diagnostics, medical devices, technological platforms and AI tools. Consult different support paths’ details below.
You can also access MATWIN’s expertise on an ad hoc basis at any time through tailor-made services. (see “Tailor-made service offers” section)
Application by October 31, 2024